ALEXION PHARMACEUTICALS INC·4

Feb 8, 7:17 PM ET

Wagner Heidi L 4

4 · ALEXION PHARMACEUTICALS INC · Filed Feb 8, 2018

Insider Transaction Report

Form 4
Period: 2018-02-06
Wagner Heidi L
SVP, Global Government Affairs
Transactions
  • Award

    Common Stock, par value $.0001 per share

    2018-02-06+4,40051,612 total
  • Sale

    Common Stock, par value $.0001 per share

    2018-02-08$116.31/sh1,774$206,33449,838 total
  • Award

    Common Stock, par value $.0001 per share

    2018-02-06+14,57747,212 total
Footnotes (4)
  • [F1]On February 6, 2018, the Leadership and Compensation Committee determined that the reporting person earned 14,577 Performance Share Units upon achievement of certain performance targets previously established by the Committee. 1/3 of such shares vested on February 6, 2018 and 1/3 vest on each subsequent anniversary.
  • [F2]On February 6, 2018, the Leadership and Compensation Committee determined that the reporting person earned 4,400 Performance Share Units upon achievement of certain performance targets previously established by the Committee. 1/4 of such shares vested on February 6, 2018 and 1/4 vest on each subsequent anniversary.
  • [F3]This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
  • [F4]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $116.00 - $116.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.

Documents

1 file
  • 4
    wf-form4_151813543967661.xmlPrimary

    FORM 4